The ratings affirmation is based on a number of factors, including SGHS’ competitive position, improved operating performance and favorable payer mix.
The outlook is stable, reflecting Moody’s Investors Service’s expectation the health system will maintain its sustained revenue growth and improved operating performance.
More articles on healthcare finance:
Fitch revises ratings watch on Tulare Regional Medical Center’s ‘BB-‘ rated bonds to negative
S&P lowers rating on Ryder Memorial Hospital’s bonds to ‘B+’
Moody’s assigns ‘Ba2’ rating to Reliant Medical Group’s bonds
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
